Cochlear traded at 185.83 this Wednesday March 4th, decreasing 6.79 or 3.53 percent since the previous trading session. Looking back, over the last four weeks, Cochlear lost 28.18 percent. Over the last 12 months, its price fell by 29.42 percent. Looking ahead, we forecast Cochlear to be priced at 191.63 by the end of this quarter and at 179.92 in one year, according to Trading Economics global macro models projections and analysts expectations.
Cochlear Limited is an Australian-based company, which provides implantable hearing solutions. The Company designs and offers products and accessories for adults or children. The Company operates through three geographical segments: Americas, EMEA and Asia Pacific. Its products offer various ways to hear, such as automatically adjusting hearing to different environments and streaming sound from a smartphone. It provides various products, including Nucleus sound processors, Smart bimodal hearing solution, Nucleus implants, Nucleus implant reliability, Baha sound processors, Baha implants, Baha Softband, SoundArc. The Company’s accessories include True Wireless devices, Nucleus water-safe accessories, Keeping device in place.